NASDAQ: ACRS Long Term Investor Alert: Investigation of Potential Wrongdoing at Aclaris Therapeutics, Inc.
An investigation on behalf of current long term investors in Aclaris Therapeutics, Inc. (NASDAQ: ACRS) shares over possible breaches of fiduciary duty by certain officers and directors was announced.
View full press release